Saving Limbs After Cancer: Blood Vessel and Soft Tissue Reconstruction Following Sarcoma Surgery in the Legs

Immediate Vascular and Soft Tissue Reconstruction After Sarcoma Resection Involving Major Limb Vessels: Early and Midterm Outcomes From a Tertiary Center

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07093320

Acronym

SARCOVASCPLAST

Enrollment

Registered

2025-07-30

Start date

2019-12-01

Completion date

2024-12-31

Last updated

2025-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Soft Tissue Sarcoma (STS)

Brief summary

This study aimed to evaluate whether immediate reconstruction of blood vessels and soft tissues can safely and effectively preserve limbs in patients undergoing surgery for sarcomas involving major arteries or veins in the arms or legs. The goal was to determine if this complex surgical approach helps avoid amputation, ensures good cancer control, and leads to acceptable complication rates and healing outcomes.

Interventions

OTHERNo intervention

No intervention

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* All consecutive patient presented with STS with major vessels involvement

Exclusion criteria

* All STS without major vessels involvement

Design outcomes

Primary

Measure	Time frame	Description
1- Limb salvage rate 2- Flap survival 3- Vascular patency	At 12 months postoperatively	1. Limb salvage: Determined by clinical documentation of limb preservation without major amputation. 2. Flap survival: Determined by clinical evaluation of flap viability 3. Vascular patency: Determined by duplex ultrasonography or CT angiography.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026